painless tracheoscopy
Conditions
Interventions
Experimental group:Propofol + revantanil + esketamine
Control group:Propofol + remifentanil
Sponsors
Beijing Chest Hospital,Capital Medical University
Eligibility
Sex/Gender
All
Age
50 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 50 to 70 years. 2. ASA I-II level. 3. Agree to participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those who are intolerant to esketamine, propofol, opioids and other drugs; 2. Patients with a history of asthma and other airway hyperresponsiveness; 3. Poorly controlled or untreated hypertension (arterial hypertension - systolic/diastolic blood pressure greater than 180/100 mmHg at rest); 4. Preoperative Child liver function classification grade 3 or above; 5. Have a history of severe cardiovascular disease (such as myocardial ischemia, heart failure and arrhythmia, etc.); 6. Patients with craniocerebral injury, possible intracranial hypertension, cerebral aneurysm, history of cerebrovascular accident and central nervous system diseases; 7. Pregnant or lactating patients; 8. Mental system diseases (schizophrenia, mania, bipolar disorder, insanity, etc.) and patients with drug history and cognitive dysfunction; 9. Those without contact information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dosage of propofol; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure;Heart rate;Choking cough;Recovery time; | — |
Countries
China
Contacts
Public ContactLiu Tao
Beijing Chest Hospital, Capital Medical Universityy
Outcome results
None listed